PetMed Express, Inc. (PETS) Tops Q2 EPS by 4c, Sales Fall Short
PetMed Express, Inc. (NASDAQ: PETS) reported Q2 EPS of $0.19, $0.04 better than the analyst estimate of $0.15. Revenue for the quarter came in at $58.2 million versus the consensus estimate of $60.56 million.